Aeris Biotechnologies, Inc.
Filings
6
Latest
253G1 · Jul 2022
Min Invest
—
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
AltStreet Analysis
·Generated from EDGAR primary sources
Aeris Biotechnologies, Inc. (DE) filed a Tier 2 Regulation A offering in April 2022 for $15.0M (security type not stated), with audited financials by BF Borgers CPA PC. At filing, the issuer was pre-revenue with $33K in assets, $33K cash, $50K long-term debt, and 2 full-time employees. The filing footprint includes only the initial 1-A and 253G1 (both April–July 2022); no subsequent 1-K or 1-SA reports are present in the corpus, suggesting the offering may have been withdrawn or reporting discontinued.
Regulation A Tier 2 offerings are qualified by the SEC and open to non-accredited retail investors nationwide, with no investment limits (Tier 1 imposes state-law caps). This appears to be an early-stage biotechnology operating company raising growth capital directly from the public, a common use case for Reg A+ by small-cap issuers seeking alternatives to venture capital or traditional IPOs.
Data Flags
EDGAR Filing Data
Form 1-A — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
6
latest Jul 27, 2022
Critical / warning
0 / 0
1 watch · 5 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
qualified
Latest event Supplement · Jul 27, 2022
SEC.govInvestor
- The dated record: 3 facts with source, effective date and capture date, viewable as AltStreet knew them on any past day
- 6 filing events with values and deltas, latest 2022-07-27, and alerts on the next one
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Auditor of Record
As named on this issuer's SEC filings · Audited · see all issuers this firm audits

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
